Goal 2-Be at the forefront of international efforts to develop new treatments for arthritis.
Treatments that accurately target arthritis will be identified for patients with most forms of arthritis reducing pain, increasing mobility and allowing a normal quality of life.
How we’ll measure progress
Our Clinical Study Groups (CSGs) will continuously review progress in the development of new treatments. The Arthritis Research UK CSGs are national research strategy setting groups established specifically to identify the major current clinical needs for patients with different forms of arthritis. They draw together the experts in the field along with patient representatives and their role is to understand the current knowledge available in the area from clinical trials and related work.
Where we are now
The situation is currently mixed and varies by type of arthritis. There have been major changes in the treatment of rheumatoid arthritis over the past 10-15 years and the impact of the disease has fallen in the UK and elsewhere. The major advance of joint replacement for severe osteoarthritis has not been matched by similar advances in managing less severe but equally disabling forms of the disease.
What we will be doing:
- Supporting a broad portfolio of world class research devoted to understanding mechanisms of pain in osteoarthritis and developing novel approaches to reducing pain
- Developing our strategy in translational research and continuing support for clinical trials.